Borsting Emily, Patel Shalin V, Declèves Anne-Emilie, Lee Sarah J, Rahman Qazi M, Akira Shizuo, Satriano Joe, Sharma Kumar, Vallon Volker, Cunard Robyn
Research Service and Division of Nephrology-Hypertension, Veterans Affairs San Diego Healthcare System, Veterans Medical Research Foundation, San Diego, California;
Center for Renal Translational Medicine, Department of Medicine, University of California San Diego, La Jolla, California; and.
J Am Soc Nephrol. 2014 Sep;25(9):2067-78. doi: 10.1681/ASN.2013070811. Epub 2014 Mar 27.
The endoplasmic reticulum (ER) stress response is activated in the diabetic kidney and functions to reduce ER protein accumulation and improve cellular function. We previously showed that tribbles homolog 3 (TRB3), an ER stress-associated protein, is upregulated in the diabetic kidney. Here, we investigated whether absence of TRB3 alters outcomes in diabetic nephropathy. Type 1 diabetes was induced in TRB3 wild-type and knockout ((-/-)) mice by low-dose streptozotocin, and the mice were followed for 12 weeks. Diabetic TRB3(-/-) mice developed higher levels of albuminuria and increased expression of inflammatory cytokine and chemokine mRNA in renal cortices relative to wild-type littermates, despite similar hyperglycemia. Diabetic TRB3(-/-) mice also expressed higher levels of ER stress-associated molecules in both the renal cortices and glomeruli. This change was associated with higher renal cortical phosphorylation of AKT at serine 473 (Ser(473)), which is the AKT site phosphorylated by mammalian target of rapamycin complex-2 (mTORC2). We show in renal tubular cells that TRB3 binds to mTOR and the rapamycin-insensitive companion of mTOR (Rictor), a protein specific to mTORC2. Finally, we demonstrate in murine tubular cells that TRB3 can inhibit secretion of IL-6. Thus, TRB3 reduces albuminuria and inflammatory gene expression in diabetic kidney disease by a mechanism that may involve inhibition of the mTORC2/AKT pathway and may prove to be a novel therapeutic target.
内质网(ER)应激反应在糖尿病肾病中被激活,其作用是减少内质网蛋白积累并改善细胞功能。我们之前发现,内质网应激相关蛋白TRIB3同源物3(TRB3)在糖尿病肾病中上调。在此,我们研究了缺失TRB3是否会改变糖尿病肾病的结局。通过低剂量链脲佐菌素诱导TRB3野生型和敲除(-/-)小鼠患1型糖尿病,并对小鼠进行12周的跟踪观察。尽管血糖水平相似,但与野生型同窝小鼠相比相比,糖尿病TRB3(-/-)小鼠出现了更高水平的蛋白尿,并且肾皮质中炎性细胞因子和趋化因子mRNA的表达增加。糖尿病TRB3(-/-)小鼠的肾皮质和肾小球中内质网应激相关分子的表达水平也更高。这种变化与肾皮质中丝氨酸473(Ser(473))位点的AKT磷酸化水平升高有关,该位点是雷帕霉素靶蛋白复合物2(mTORC2)磷酸化的AKT位点。我们在肾小管细胞中发现TRB3与mTOR以及mTOR的雷帕霉素不敏感伴侣Rictor结合,Rictor是mTORC2特有的一种蛋白质。最后,我们在小鼠肾小管细胞中证明TRB3可以抑制IL-6的分泌。因此,TRB3通过一种可能涉及抑制mTORC2/AKT途径的机制降低糖尿病肾病中的蛋白尿和炎性基因表达,可能成为一个新的治疗靶点。